A biotechnology company based in Winston-Salem wants to raise $1.25 million in a private offering, according to a Securities and Exchange Commission filing.

Of the $1.25 million, KeraNetics LLC plans to use $275,000 for to pay for the salary for its CEO and managing director.

The filing can be found here.

KeraNetics develops and manufactures purified keratin medical products, which are used to treat burn victims and for muscle regeneration. Last year, it received a $1 million contract from the U.S. Department of Defense for pre-clinical testing and a safety trial of KeraGenics Muscle for the treatment of volumetric muscle loss.

The company holds patents for methods of purifying keratin proteins and for fields of use in regenerative medicine and trauma.

The company’s chief executive officer is Kim Westmoreland, who has has over 25 years of experience as a serial entrepreneur and has founded six start-up companies including KeraNetics. Westmoreland is the former assistant dean of the Wake Forest University School of Business.

Private companies similar to KeraNetics, which rely on a Reg D exemption, aren’t required to register securities offerings with the SEC, but instead they must file a Form D electronically with the SEC after they sell the securities.